Human Cancer Associated Endothelial Cells — Save 20.00% OFF sitewide! Use Code: CAE2026 Shop Now

Human Diabetic Primary Kidney Vein Fibroblast Cells

NBPDF009 Primary Cells
$900.00
Starting price per unit
Human Diabetic Primary Kidney Vein Fibroblast Cells
In Stock 1ml
Product Type Human Type II Diabetes E…
Viability >95% viable (Trypan Blue exclusion)
Storage Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life Very stable in the Liquid Nitrogen Vapor Phase

Quick Actions

Quality Certified
Global Shipping Available
Technical Support Included
Documentation 1 files

Product Overview

Description

Human Diabetic Primary Kidney Vein Fibroblast Cells are specialized cells derived from the kidney's venous tissue of individuals with diabetes. These fibroblasts play a crucial role in the kidney's structural integrity and function, as they contribute to the extracellular matrix and support the surrounding tissues.

Guarantee expansion for a minimum of 2-5 population
doublings.

IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.

Key Features

Catalog Number: NBPDF009
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)

Cell Characteristics

Primary Cells: These are isolated directly from human tissue (kidney vein) and have not been immortalized. They have a finite lifespan and closely mimic the in vivo physiological state.

Diabetic Origin: The donor has a confirmed diagnosis of diabetes mellitus (often Type II). These cells retain the epigenetic and metabolic memory of the diabetic state (e.g., increased basal expression of inflammatory cytokines, altered glucose metabolism).

Anatomical Location: The renal vein is the vessel that carries filtered blood away from the kidney. Fibroblasts from this site are crucial for studying vascular fibrosis and the structural changes in the kidney's vascular outflow tract under hyperglycemic conditions.

Quick Facts
Product Type

Human Type II Diabetes Endothelial Cells

Viability

>95% viable (Trypan Blue exclusion)

Applications

Diabetic Nephropathy: Investigating the mechanism…

Availability

In Stock • Global Shipping

Technical Specifications

Product Type
Human Type II Diabetes Endothelial Cells
Viability
>95% viable (Trypan Blue exclusion)
Proliferative Capability
Primary cells capable of multiple passages when using recommended medium and proper handling
Storage Conditions
Store in liquid nitrogen vapor phase (-196°C) for long-term. Ship on dry ice (-80°C).
Shelf Life
Very stable in the Liquid Nitrogen Vapor Phase
Product Code
NBPDF009
Size/Format
1ml
Primary Applications
Diabetic Nephropathy: Investigating the mechanisms of renal fibrosis extracellular matrix (ECM) accumulation (Collagen I Fibronectin) and the epithelial-mesenchymal transition (EMT) signaling pathways. Inflammation: Examining the role of hyperglycemia in activating NF-B and releasing IL-6 TNF- and MCP-1. Drug Screening: Testing anti-fibrotic agents (e.g. SGLT2 inhibitors GLP-1 analogs or TGF- inhibitors) in a cell type directly relevant to diabetic complications. Vascular Remodeling: Understanding how high glucose environments affect the structural integrity of the renal venous system.

Applications & Use Cases

Primary Applications
Diabetic Nephropathy: Investigating the mechanisms of renal fibrosis

Suitable for diabetic nephropathy: investigating the mechanisms of renal fibrosis studies and research applications

extracellular matrix (ECM) accumulation (Collagen I

Suitable for extracellular matrix (ecm) accumulation (collagen i studies and research applications

Fibronectin)

Suitable for fibronectin) studies and research applications

and the epithelial-mesenchymal transition (EMT) signaling pathways. Inflammation: Examining the role of hyperglycemia in activating NF-B and releasing IL-6

Suitable for and the epithelial-mesenchymal transition (emt) signaling pathways. inflammation: examining the role of hyperglycemia in activating nf-b and releasing il-6 studies and research applications

TNF-

Suitable for tnf- studies and research applications

and MCP-1. Drug Screening: Testing anti-fibrotic agents (e.g.

Suitable for and mcp-1. drug screening: testing anti-fibrotic agents (e.g. studies and research applications

SGLT2 inhibitors

Suitable for sglt2 inhibitors studies and research applications

GLP-1 analogs

Suitable for glp-1 analogs studies and research applications

or TGF- inhibitors) in a cell type directly relevant to diabetic complications. Vascular Remodeling: Understanding how high glucose environments affect the structural integrity of the renal venous system.

Suitable for or tgf- inhibitors) in a cell type directly relevant to diabetic complications. vascular remodeling: understanding how high glucose environments affect the structural integrity of the renal venous system. studies and research applications

Research Areas
In Vitro Studies

Cell culture and screening applications

Molecular Biology

Gene expression & signaling studies

Drug Discovery

Screening & validation studies

Disease Modeling

Pathophysiology research

Support & Resources

Technical Support

Our experts are available for technical questions and protocol assistance.

Contact Support
Documentation

Access product datasheets, protocols, and certificates.

Request Documentation
Shipping & Logistics

Temperature-controlled shipping to 40+ countries worldwide.

Shipping Info
FAQ & Resources

Find answers to common questions and optimization tips.

View FAQs

Our Worldwide Locations

Find a distributor near you

MoreBio

MoreBio

Advancing Life Science, Globally

Address F810, Testa Tower, 25, Misagangbyeonseo-ro
Hanam-si, Gyeonggi-do, Republic of Korea, 12918
Korea
Contact yhwoo@morebio.co.kr
+82-2-406-2942
+82-31-735-2944